Conv. Plasma
Nigella Sativa
Peg.. Lambda

All selenium studies
Meta analysis
Home COVID-19 treatment researchSeleniumSelenium (more..)
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta
Cannabidiol Meta Molnupiravir Meta
Colchicine Meta
Conv. Plasma Meta
Curcumin Meta Nigella Sativa Meta
Ensovibep Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Peg.. Lambda Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Ivermectin Meta
Lactoferrin Meta

All Studies   Meta Analysis   Recent:  

Association between regional selenium status and reported outcome of COVID-19 cases in China

Zhang et al., The American Journal of Clinical Nutrition, doi:10.1093/ajcn/nqaa095
Jun 2020  
  Source   PDF   All Studies   Meta AnalysisMeta
Analysis of COVID-19 outcomes and selenium status in China, showing higher selenium levels correlated with a higher recovery rate.
Zhang et al., 30 Jun 2020, retrospective, China, peer-reviewed, 5 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperSeleniumAll
Association between regional selenium status and reported outcome of COVID-19 cases in China
Jinsong Zhang, Ethan Will Taylor, Kate Bennett, Ramy Saad, Margaret P Rayman
The American Journal of Clinical Nutrition, doi:10.1093/ajcn/nqaa095
Potentially relevant to the recent appearance of COVID-19 in China is the fact that there is a belt of selenium deficiency running from northeast to southwest in the country and, indeed, China has populations that have both the lowest and the highest selenium status in the world (1). A set of interesting studies published by the Beck laboratory in the 1990s showed that host selenium deficiency increased the virulence of RNA viruses such as coxsackievirus B3 and influenza A (2, 3). Passage through a selenium-deficient animal that was unable to produce sufficient antioxidant selenoproteins for its own protection resulted in the virus mutating to a virulent form that caused more severe pathology (2, 3). Those findings shed light on a human selenium-deficiency disease, a cardiomyopathy known as Keshan disease, named after the area in northeast China where it was endemic. The disease showed a seasonal variation, suggesting a viral cofactor that was later identified as coxsackievirus B3 (2). When the population was supplemented with selenium, the incidence of Keshan disease decreased dramatically (1, 2). Significant clinical benefits of selenium supplementation have also been demonstrated in other viral infections, as reviewed previously (4, 5), including HIV-1 [where a negative correlation between selenium status and mortality has been established (1, 6)]; in liver cancer linked to hepatitis B; and in patients with "epidemic hemorrhagic fever" that was successfully treated with oral sodium selenite, giving an overall 80% reduction in mortality (4, 7). As such, selenium appears relevant to a number of evolutionarily distinct viruses, via potential immunomodulatory effects that are fully consistent with the many essential roles of selenium in the immune system (2) and its ability (especially in deficiency) to influence viral mutation and evolution (3). These and other studies prompted us to hypothesize that selenium status was associated with COVID-19 disease outcome in China. In this population-based, retrospective analysis, we collected realtime data from the Baidu website, a nongovernmental website that provides daily updates of the reports of the health commissions of each province, municipality, or city on numbers of COVID-19 confirmed cases, numbers cured, and numbers who died (8). [According to the National Health Commission of China, cured patients are those in whom temperature has returned to normal for >3 d, respiratory symptoms are significantly improved, lung imaging shows significant reduction of inflammation, and there is a negative nucleic acid test of respiratory pathogen on 2 consecutive occasions with a sampling interval of at least 1 d ( 9 ).] Cure rate and death rate were defined as percentage of patients cured or who died, respectively, from infection with SARS-CoV-2. We tracked the course of the outbreak from 14 February and chose data from 18 February as a "snapshot" of the progress of the outbreak to that..
Baidu, Epidemic real-time big data report
Baidu, the discharge standard of patients with new coronary pneumonia is unified nationally
Baum, Shor-Posner, Lai, Zhang, Lai et al., High risk of HIV-related mortality is associated with selenium deficiency, J Acquir Immune Defic Syndr Hum Retrovirol
Beck, Handy, Levander, Host nutritional status: the neglected virulence factor, Trends Microbiol
Dinh, Cui, Huang, Tran, Wang et al., Selenium distribution in the Chinese environment and its relationship with human health: a review
Guillin, Vindry, Ohlmann, Chavatte, Selenium, selenoproteins and viral infection, Nutrients
Hoffmann, Berry, The influence of selenium on immune responses, Mol Nutr Food Res
Hou, Inhibitory effect of selenite and other antioxidants on complement-mediated tissue injury in patients with epidemic hemorrhagic fever, Biol Trace Elem Res
Huang, Wang, Gao, Lin, Banuelos et al., Daily dietary selenium intake in a high selenium area of Enshi, China, Nutrients
Li, Banuelos, Wu, Shi, The changing selenium nutritional status of Chinese residents, Nutrients
Rayman, Selenium and human health, Lancet
Steinbrenner, Al-Quraishy, Dkhil, Wunderlich, Sies, Dietary selenium in adjuvant therapy of viral and bacterial infections, Adv Nutr
Taylor, Ruzicka, Premadasa, Zhao, Cellular selenoprotein mRNA tethering via antisense interactions with Ebola and HIV-1 mRNAs may impact host selenium biochemistry, Curr Top Med Chem
Yang, Xia, Studies on human dietary requirements and safe range of dietary intakes of selenium in China and their application in the prevention of related endemic diseases, Biomed Environ Sci
Zhao, Cox, Ruzicka, Bhat, Zhang et al., Molecular modeling and in vitro activity of an HIV-1-encoded glutathione peroxidase, Proc Natl Acad Sci
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop